Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Colorectal Neoplasms × sotorasib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

KRAS p.G12C Mutant Advanced Solid Tumors 1 Colorectal Neoplasms 1

Interventions

Cetuximab 5 Bevacizumab 4 pembrolizumab 3 Leucovorin 3 Irinotecan 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 trastuzumab deruxtecan 2 encorafenib 2 Oxaliplatin 2 HMPL-013 2 tucatinib 1 sotorasib 1 regorafenib 1 pralsetinib 1 larotrectinib 1 entrectinib 1 binimetinib 1 adagrasib 1 Trastuzumab 1 Panitumumab 1 Nivolumab 1 Levoleucovorin 1 Ipilimumab 1 IFL protocol 1 Capecitabine 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05198934 2026-02-06

CodeBreak300

Amgen

Phase 3 Active not recruiting

160 enrolled 1 FDA

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡